By Counterforce Health Team in Qalsody (tofersen) —

How to Get Qalsody (Tofersen) Covered by Humana in Georgia: Complete Prior Authorization Guide

Answer Box: Getting Qalsody (Tofersen) Covered by Humana in Georgia

Eligibility: Qalsody requires confirmed ALS with documented SOD1 mutation, neurologist prescriber, and baseline ALSFRS-R/vital capacity testing. Fastest approval path: Submit complete prior authorization with genetic testing results, clinical notes, and baseline assessments through Humana's provider portal or specialty pharmacy. Start today: Contact your neurologist to order SOD1 genetic testing if not done, and request ALSFRS-R baseline scoring. Appeals must be filed within 65 days in Georgia, with external review available through the Georgia Department of Insurance if denied.

Table of Contents

  1. What This Guide Covers
  2. Before You Start: Verify Your Coverage
  3. Gather Required Documentation
  4. Submit Your Prior Authorization Request
  5. Follow-Up and Tracking
  6. Common Denial Reasons and Fixes
  7. Appeals Process in Georgia
  8. Renewal and Reauthorization
  9. Costs and Patient Assistance
  10. FAQ
  11. Quick Reference Checklist

What This Guide Covers

This comprehensive guide helps ALS patients and their families navigate Humana's prior authorization process for Qalsody (tofersen) in Georgia. Qalsody is the first FDA-approved treatment specifically for ALS caused by SOD1 gene mutations, but getting insurance coverage requires careful documentation and persistence.

Who this helps: Patients with confirmed or suspected SOD1-positive ALS, their caregivers, and healthcare providers working with Humana Medicare Advantage, Medicare Part D, or commercial plans in Georgia.

Expected outcomes: With proper documentation, most eligible patients can achieve approval within 30 days for initial requests, or successfully appeal denials using Georgia's robust external review process.

Before You Start: Verify Your Coverage

Check Your Plan Type and Benefits

First, determine whether you have Humana Medicare Advantage (Part C), Medicare Part D, or a commercial plan, as this affects your appeal rights and timelines.

Verify coverage details:

  • Log into your Humana member portal to check your formulary
  • Qalsody typically appears on Tier 4 (Specialty) if covered
  • Confirm your plan includes specialty pharmacy benefits
  • Note any "Limited Access" (LA) indicators requiring specific pharmacies

Confirm Network Status

Ensure your prescribing neurologist is in-network with Humana. Out-of-network prescribers can complicate prior authorization and increase costs.

Key requirement: Qalsody must be prescribed by or in consultation with a neurologist experienced in ALS care. In Georgia, the Emory ALS Center (404-778-3444) is the primary specialist center.

Gather Required Documentation

Essential Medical Records

1. ALS Diagnosis Confirmation

  • Clinical notes establishing ALS diagnosis (preferably using El Escorial or Awaji criteria)
  • ICD-10 code G12.21 (Motor neuron disease)
  • Neurologist's assessment and treatment plan

2. SOD1 Genetic Testing Results

  • Laboratory report showing pathogenic SOD1 mutation
  • Genetic counseling records (pre- and post-test)
  • Family history documentation if available

3. Functional Assessments

  • Baseline ALSFRS-R (ALS Functional Rating Scale-Revised) score within 6 months
  • Slow Vital Capacity (SVC) ≥50-65% of predicted
  • Documentation that patient is not dependent on invasive ventilation or tracheostomy

4. Baseline Biomarkers

  • Plasma neurofilament light chain (NfL) level if available
  • Other relevant lab work supporting diagnosis

Prior Authorization Forms

Access Humana's current prior authorization forms through their provider portal or request Qalsody-specific forms from your specialty pharmacy.

Tip: Many specialty pharmacies will handle the PA submission for you, but ensure they have all required documentation before starting.

Submit Your Prior Authorization Request

Step-by-Step Submission Process

1. Complete the PA Form (Provider/Pharmacy)

  • Use Humana's drug-specific form for Qalsody
  • Include all required clinical criteria
  • Attach supporting documentation

2. Submit Through Preferred Channel

  • Online: Humana provider portal (fastest processing)
  • Fax: Use number provided on PA form
  • Specialty Pharmacy: Many handle submissions directly

3. Include Complete Documentation Package

  • Completed PA form with all fields
  • Clinical notes and diagnosis confirmation
  • SOD1 genetic testing results
  • Baseline functional assessments
  • Prescriber attestation of medical necessity

Medical Necessity Letter Checklist

Your neurologist should include these elements in their medical necessity letter:

  • Problem Statement: ALS diagnosis with confirmed SOD1 mutation
  • Treatment History: Any prior ALS therapies (riluzole, edaravone) and responses
  • Clinical Rationale: Why Qalsody is appropriate for this patient's specific mutation
  • Dosing Plan: FDA-approved intrathecal dosing (100 mg every 28 days after loading)
  • Monitoring Plan: ALSFRS-R tracking, safety assessments
  • Guidelines Reference: FDA approval and clinical trial data

Follow-Up and Tracking

Timeline Expectations

  • Standard Review: Up to 30 days for commercial plans
  • Medicare Part D: 7 days for standard, 72 hours for expedited
  • Expedited Review: Available when delay could jeopardize health

Tracking Your Request

Contact Humana directly:

  • Use member services number on your insurance card
  • Reference your PA request number
  • Document all interactions with date, time, and representative name

Sample phone script: "I'm calling to check the status of prior authorization request #[number] for Qalsody tofersen. Can you tell me if any additional information is needed and when I can expect a decision?"

Common Denial Reasons and Fixes

Denial Reason How to Fix Documentation Needed
No SOD1 mutation documented Submit genetic testing results Laboratory report with pathogenic SOD1 variant
Non-neurologist prescriber Get neurologist consultation Referral or co-signature from ALS specialist
Missing baseline assessments Complete required testing ALSFRS-R score, vital capacity testing
"Experimental" designation Reference FDA approval FDA label, CMS coverage guidance (Dec 2024)
Ventilator dependency Clarify ventilation status Clinical notes confirming non-invasive support only

Recent CMS Guidance

In December 2024, CMS directed Medicare Advantage plans to cover Qalsody for on-label SOD1-ALS use, overturning many "experimental" denials. Reference this guidance in appeals for Medicare Advantage denials.

Appeals Process in Georgia

Internal Appeals (First Level)

Timeline: 65 days from denial notice to file appeal

  • Medicare Part D: 7 days standard, 72 hours expedited
  • Medicare Advantage: 30 days standard, 72 hours expedited

How to file: Use Humana's online appeals portal or call member services.

External Review (Georgia Department of Insurance)

If Humana upholds their denial, Georgia residents can request external review through the state insurance department.

Key details:

  • Deadline: 60 days from final internal denial
  • Cost: Free to consumers
  • Timeline: 30 business days (72 hours if urgent)
  • Contact: Georgia DOI Consumer Services at 1-800-656-2298

Required documents:

  • Completed external review application
  • Copy of denial letters (initial and internal appeal)
  • All medical records supporting medical necessity
  • Provider letter explaining why treatment is needed
Note: Georgia's external review decision is binding on the insurer and provides powerful protection for consumers facing wrongful denials.

Renewal and Reauthorization

Planning Ahead

Most initial Qalsody approvals are for 6-12 months. Set calendar reminders to begin renewal 30-60 days before expiration.

Renewal documentation:

  • Updated ALSFRS-R scores showing stability or improvement
  • Provider assessment of clinical benefit
  • Continued absence of ventilator dependency
  • Any new safety or efficacy data

Demonstrating Clinical Benefit

Work with your neurologist to document treatment response through:

  • ALSFRS-R score trends
  • Biomarker improvements (NfL levels)
  • Functional assessments
  • Quality of life measures

Costs and Patient Assistance

Expected Costs

Qalsody's list price is approximately $14,230-$14,754 per monthly dose, with first-year costs around $200,000-$220,000 including loading doses.

Humana Tier 4 (Specialty) typical costs:

  • 25-33% coinsurance after deductible
  • Annual out-of-pocket maximums apply
  • Medicare Part D catastrophic coverage may reduce costs significantly

Patient Assistance Programs

Biogen Support: Contact the manufacturer for copay assistance and patient support programs. Visit qalsodyhcp.com for current programs.

Additional resources:

  • Patient Advocate Foundation
  • National Organization for Rare Disorders (NORD)
  • ALS Association financial assistance programs

FAQ

Q: How long does Humana prior authorization take for Qalsody in Georgia? A: Standard review is up to 30 days for commercial plans, 7 days for Medicare Part D. Expedited review is available within 72 hours when medically necessary.

Q: What if Qalsody isn't on Humana's formulary? A: Request a formulary exception with medical necessity documentation. The December 2024 CMS guidance supports coverage for Medicare Advantage plans.

Q: Can I get expedited approval if my ALS is progressing rapidly? A: Yes, you or your prescriber can request expedited review if waiting would jeopardize your health. Provide clinical documentation supporting urgency.

Q: What happens if I'm denied after internal appeal? A: Georgia residents can request external review through the state insurance department within 60 days. This independent review is free and binding on the insurer.

Q: Do I need to try other ALS medications first? A: Step therapy requirements vary by plan, but Qalsody targets a specific genetic form of ALS. Your neurologist should document why SOD1-targeted therapy is uniquely appropriate.

Q: How do I find an ALS specialist in Georgia? A: The Emory ALS Center in Atlanta is the primary specialist center, reachable at 404-778-3444. They can provide SOD1 testing and Qalsody prescribing.

Quick Reference Checklist

Before Starting:

  • Confirm ALS diagnosis with neurologist
  • Complete SOD1 genetic testing
  • Obtain baseline ALSFRS-R and vital capacity
  • Verify Humana coverage and specialty pharmacy benefits

For Prior Authorization:

  • Complete Humana PA form
  • Attach genetic testing results
  • Include clinical notes and diagnosis codes
  • Submit baseline functional assessments
  • Provide medical necessity letter

If Denied:

  • File internal appeal within 65 days
  • Request expedited review if urgent
  • Prepare for external review with Georgia DOI
  • Document all interactions and deadlines

For Renewal:

  • Schedule renewal 60 days before expiration
  • Update ALSFRS-R and clinical assessments
  • Document treatment response and benefit
  • Submit continuation request with updated records

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with each payer's specific requirements, significantly improving approval rates for complex medications like Qalsody.

When navigating complex prior authorizations like those for Qalsody, having expert support can make the difference between approval and denial. Counterforce Health specializes in transforming insurance denials into successful appeals by identifying the specific denial basis and crafting targeted responses using the right clinical evidence and payer-specific workflows.

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage and appeals processes. It is not medical advice, legal advice, or a guarantee of coverage. Always consult with your healthcare provider about treatment decisions and verify current insurance policies and procedures with your plan. Coverage policies and appeal procedures may change; confirm current requirements with official sources.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.